Jade Biosciences, Inc. (JBIO)
Develops experimental antibody drugs to treat autoimmune diseases
$19.70-0.01%Healthcare
StockGlow Score
Leaning Bullish
BearishBullish
1 year ago+185.9%
The outlook
JBIO is trading near the middle of its 52-week range with mixed momentum versus its moving averages. Analyst sentiment leans bullish, with an average price target about 146% above the current price, though this represents a significant gap between current levels and consensus expectations. The stock showed no movement today.
What’s behind the score
Price trendMixed vs its moving averages
52-week range61% of the way from its 52-week low to high
Price targetAvg target +146% vs current price
Analyst price target
~12-month · 8 analysts$48.50average target+146.2% vs now
Now $19.70
Low $40.00High $74.00
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
$1.20B
52-wk high
$28.00
52-wk low
$6.67
50-day avg
$20.13
200-day avg
$16.31
Trailing P/E
—